Indeed, ADAP2 has been shown to be upregulated by IFN treatment in various human cells, such as primary hepatocytes [42] and PBMCs isolated from multiple sclerosis patients undergoing IFN treatments [43]. Here, IFNA1 is linked to multiple sclerosis.